This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 19, 2024. The award, valued at $17,585.58, is for the delivery of Dupixent 300 mg/2 ml pens. It is a firm fixed-price delivery order that runs through November 20, 2024.
AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award appears to be part of that broader IDC. The contract has no set-aside designation, indicating open competition.
Generated 2/18/25, 1:32 PM